📗 Cite This Artifact
Neurotrophic Signaling Pathway
Neurotrophic Signaling Pathway
Overview
The neurotrophic signaling pathway describes the intracellular cascades activated by neurotrophin receptors to promote neuronal survival, differentiation, and synaptic plasticity. This pathway is fundamental to nervous system development and maintenance, and its dysregulation is implicated in multiple neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis[@chao2014].
This page describes the molecular mechanisms of neurotrophin receptor signaling. For information about specific neurotrophic factors, see [Neurotrophic Factors in Neurodegeneration](/mechanisms/neurotrophic-factors).
Trk Receptor Signaling
Receptor Structure and Activation
The Trk (tropomyosin receptor kinase) family includes TrkA, TrkB, and TrkC, each serving as high-affinity receptors for specific neurotrophins:
Neurotrophic Signaling Pathway
Overview
The neurotrophic signaling pathway describes the intracellular cascades activated by neurotrophin receptors to promote neuronal survival, differentiation, and synaptic plasticity. This pathway is fundamental to nervous system development and maintenance, and its dysregulation is implicated in multiple neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis[@chao2014].
This page describes the molecular mechanisms of neurotrophin receptor signaling. For information about specific neurotrophic factors, see [Neurotrophic Factors in Neurodegeneration](/mechanisms/neurotrophic-factors).
Trk Receptor Signaling
Receptor Structure and Activation
The Trk (tropomyosin receptor kinase) family includes TrkA, TrkB, and TrkC, each serving as high-affinity receptors for specific neurotrophins:
- TrkA: Primary receptor for [nerve growth factor (NGF) ](/proteins/nerve-growth-factor)
- TrkB: Primary receptor for [brain-derived neurotrophic factor (BDNF) ](/proteins/brain-derived-neurotrophic-factor) and NT-4/5
- TrkC: Primary receptor for neurotrophin-3 (NT-3)
Ligand binding induces receptor dimerization and autophosphorylation at specific tyrosine residues, creating docking sites for downstream signaling adaptors[@patapoutian2001].
PI3K/AKT Pathway
The PI3K/AKT pathway is the primary mediator of neurotrophin-induced neuronal survival. Activated Trk receptors recruit PI3K to the membrane, where it phosphorylates PIP2 to generate PIP3. AKT (protein kinase B) is then recruited to the membrane and activated by PDK1-dependent phosphorylation. Active AKT phosphorylates multiple targets that promote cell survival, including BAD, caspase-9, and GSK-3β[@soehnlein2017].
Key downstream effects:
- Phosphorylation and inactivation of pro-apoptotic proteins (BAD, Bax)
- Activation of NF-κB survival signaling
- Regulation of mitochondrial function
- Modulation of autophagy
The PI3K/AKT pathway is critically impaired in Alzheimer's disease, contributing to tau hyperphosphorylation and amyloid-β toxicity[@Huang2022].
RAS/ERK Pathway
The RAS/ERK (extracellular signal-regulated kinase) pathway mediates the differentiation and plasticity effects of neurotrophins. Following Trk activation, RAS is recruited to the membrane and activated through a Grb2/SOS-dependent mechanism. Activated RAS initiates a kinase cascade involving Raf, MEK, and ERK[@patapoutian2001].
Key downstream effects:
- Phosphorylation of transcription factors (c-Fos, c-Myc)
- Activation of ribosomal S6 kinase (RSK)
- Regulation of synaptic plasticity and LTP
- Neuronal differentiation
In neurodegeneration, ERK signaling has complex roles—it can be protective in some contexts but may contribute to pathological processes when chronically activated.
PLC-γ Pathway
The PLC-γ pathway is activated by direct binding of phospholipase C-γ (PLC-γ) to phosphorylated Trk receptors. PLC-γ hydrolyzes PIP2 to generate IP3 and DAG, leading to calcium release from intracellular stores and activation of protein kinase C (PKC)[@patapoutian2001].
Key downstream effects:
- Calcium release from intracellular stores
- PKC activation and downstream signaling
- Modulation of synaptic transmission
- Regulation of ion channel function
p75^NTR Signaling
The p75 neurotrophin receptor (p75^NTR) can bind all neurotrophins with similar affinity and modulates the signaling outcomes of Trk receptors. When expressed alone, p75^NTR typically promotes apoptosis through activation of the NF-κB pathway and JNK kinase cascades[@chao2014].
Pro-Apoptotic Signaling
The apoptotic signaling cascade initiated by p75^NTR involves:
- Recruitment of TRAF6 and activation of the IKK complex
- NF-κB activation (which can paradoxically promote survival in some contexts)
- JNK activation through ASK1, leading to apoptosis
In neurodegenerative diseases, p75^NTR expression is often upregulated in vulnerable neuronal populations, and this upregulation is associated with increased apoptosis.
Ligand-Dependent Signaling Switch
p75^NTR can promote either survival or death depending on:
- Co-receptor expression (Trk vs. sortilin)
- Ligand form (mature neurotrophin vs. proneurotrophin)
- Cellular context
Pro-neurotrophins binding to p75^NTR/sortilin complexes preferentially trigger apoptosis, while mature neurotrophins promoting Trk-mediated survival.
Disease Implications
Alzheimer's Disease
In Alzheimer's disease, multiple components of neurotrophin signaling are disrupted:
- TrkA and TrkB signaling impaired through reduced receptor expression
- Amyloid-β directly binds p75^NTR to promote apoptotic signaling
- Tau pathology disrupts axonal transport of neurotrophin-containing vesicles
- Impaired retrograde transport of NGF to basal forebrain cholinergic neurons[@Huang2022]
Parkinson's Disease
In Parkinson's disease, neurotrophin signaling is compromised:
- Reduced BDNF expression in the substantia nigra
- Alpha-synuclein oligomers interfere with retrograde transport
- Impaired TrkB signaling in dopaminergic neurons
- p75^NTR upregulation in vulnerable neuronal populations
Amyotrophic Lateral Sclerosis
In ALS, neurotrophin signaling fails through:
- Reduced TrkB expression in spinal motor neurons
- Mutant SOD1 interference with neurotrophin signaling
- Insufficient trophic support for motor neurons
Therapeutic Implications
Small Molecule Trk Agonists
The development of small molecule Trk agonists represents a promising approach to enhance neurotrophin signaling. Unlike native neurotrophins, these small molecules can cross the blood-brain barrier and are suitable for chronic oral administration.
Gene Therapy
AAV-mediated delivery of neurotrophin genes offers potential for sustained expression in target brain regions. Challenges include achieving appropriate spatial and temporal expression without causing side effects.
See Also
- [Neurotrophic Factors in Neurodegeneration](/mechanisms/neurotrophic-factors)
- [Brain-Derived Neurotrophic Factor (BDNF) ](/proteins/brain-derived-neurotrophic-factor)
- [Nerve Growth Factor (NGF) ](/proteins/nerve-growth-factor)
- [Trk Receptor](/proteins/trk-receptor)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | mechanisms-neurotrophic-signaling-pathway |
| kg_node_id | None |
| entity_type | mechanism |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-39ec31b5ac7b |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'mechanisms-neurotrophic-signaling-pathway'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-mechanisms-neurotrophic-signaling-pathway?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[Neurotrophic Signaling Pathway](http://scidex.ai/artifact/wiki-mechanisms-neurotrophic-signaling-pathway)
http://scidex.ai/artifact/wiki-mechanisms-neurotrophic-signaling-pathway